National Institute for Clinical Excellence and its value judgments
Top Cited Papers
- 22 July 2004
- Vol. 329 (7459) , 224-227
- https://doi.org/10.1136/bmj.329.7459.224
Abstract
The National Institute for Clinical Excellence (NICE) offers health professionals in England and Wales advice on providing NHS patients with the highest attainable standards of care.1 NICE gives guidance on individual health technologies, the management of specific conditions, and the safety and efficacy of interventional diagnostic and therapeutic procedures. Guidance is based on the best available evidence. The evidence may not, however, be very good and is rarely complete. Those responsible for formulating the NICE's advice therefore have to make judgments both about what is good and bad in the available science (scientific value judgments) and about what is good for society (social value judgments). In this article we focus on the scientific and social judgments forming the crux of the institute's assessment of cost effectiveness. Scientific value judgments and those relating to clinical effectiveness are considered elsewhere.2Keywords
This publication has 10 references indexed in Scilit:
- Equity - some theory and its policy implicationsJournal of Medical Ethics, 2001
- Economics and ethics in health careJournal of Medical Ethics, 2001
- Sample size calculations in studies using the EuroQol 5DQuality of Life Research, 1999
- The rationing debate: Maximising the health of the whole community. The case forBMJ, 1997
- A Review of the Progress Towards Developing Health-Related Quality-of-Life Instruments for International Clinical Studies and Outcomes ResearchPharmacoEconomics, 1996
- EuroQol: the current state of playHealth Policy, 1996
- Need: The idea won't do—But we still need itSocial Science & Medicine, 1995
- Equity and equality in health and health careJournal of Health Economics, 1993
- Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaireQuality of Life Research, 1993
- How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1992